Stemina Biomarker Discovery, Inc. is a metabolomics company organized around molecular biomarkers to improve drug safety and human health. The company works on collaborative research projects and joint development agreements with strategic partners to develop drugs, identify targets, and discover molecular biomarkers for the diagnosis of diseases and customized treatment. An example of such an alliance would be that with Integrated Laboratory Systems, Inc. Stamina Biomarker provides metabolomics and mass spectrometry services, as well as develops diagnostic biomarkers. The company's cell-based assays arise from the strategic convergence of technologies, such as human embryonic stem (hES) cells and metabolomics. Using mass spectrometry to analyze the small molecules secreted by hES, heart, and neural cells in response to drugs, injury, or disease, Stemina's lead product is an assay for autism-spectrum diagnosis.
